Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden i...

Full description

Saved in:
Bibliographic Details
Main Authors: Canrong Wu (Author), Yang Liu (Author), Yueying Yang (Author), Peng Zhang (Author), Wu Zhong (Author), Yali Wang (Author), Qiqi Wang (Author), Yang Xu (Author), Mingxue Li (Author), Xingzhou Li (Author), Mengzhu Zheng (Author), Lixia Chen (Author), Hua Li (Author)
Format: Book
Published: Elsevier, 2020-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ec603b83fe2e4400ad6a3c1f70995d97
042 |a dc 
100 1 0 |a Canrong Wu  |e author 
700 1 0 |a Yang Liu  |e author 
700 1 0 |a Yueying Yang  |e author 
700 1 0 |a Peng Zhang  |e author 
700 1 0 |a Wu Zhong  |e author 
700 1 0 |a Yali Wang  |e author 
700 1 0 |a Qiqi Wang  |e author 
700 1 0 |a Yang Xu  |e author 
700 1 0 |a Mingxue Li  |e author 
700 1 0 |a Xingzhou Li  |e author 
700 1 0 |a Mengzhu Zheng  |e author 
700 1 0 |a Lixia Chen  |e author 
700 1 0 |a Hua Li  |e author 
245 0 0 |a Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods 
260 |b Elsevier,   |c 2020-05-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 10.1016/j.apsb.2020.02.008 
520 |a SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden infectious diseases. We systematically analyzed all the proteins encoded by SARS-CoV-2 genes, compared them with proteins from other coronaviruses, predicted their structures, and built 19 structures that could be done by homology modeling. By performing target-based virtual ligand screening, a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products. Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro), Spike, RNA-dependent RNA polymerase (RdRp), and papain like protease (PLpro) were discussed in detail. In addition, a database of 78 commonly used anti-viral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed. Possible targets of these compounds and potential drugs acting on a certain target were predicted. This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2, new insights for those drugs currently ongoing clinical studies, and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections. 
546 |a EN 
690 |a SARS-CoV-2 
690 |a Drug repurposing 
690 |a Molecular docking 
690 |a Remdesivir 
690 |a Homology modeling 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 10, Iss 5, Pp 766-788 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383520302999 
787 0 |n https://doaj.org/toc/2211-3835 
856 4 1 |u https://doaj.org/article/ec603b83fe2e4400ad6a3c1f70995d97  |z Connect to this object online.